Doxazosin Mesylate

Product NDC: 60429-954
11-digit product format: 604290954
Labeler code: 60429
Product ID: 60429-954_c0961b16-013c-e89f-e053-2995a90a1a59
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Doxazosin Mesylate
Dosage form: TABLET
Route: ORAL
Labeler: Golden State Medical Supply, Inc.
Application: ANDA076161
Marketing category: ANDA
Marketing start: 2011-07-20
Marketing end: 0000-00-00
Substance: DOXAZOSIN MESYLATE
Active strength: 2 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	60429-954		D	Discontinued by firm	2026-08-03
excluded package	package	60429-954	60429-954-01	D	Discontinued by firm	2026-08-03
excluded package	package	60429-954	60429-954-10	D	Discontinued by firm	2026-08-03
excluded package	package	60429-954	60429-954-90	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	60429-954-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	60429-954-90	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	60429-954-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	60429-954-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	60429-954-90	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	60429-954-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	60429-954-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	60429-954-90	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	60429-954-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	60429-954-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	60429-954-90	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	60429-954-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	60429-954-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	60429-954-90	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	60429-954-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	60429-954-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	60429-954-90	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	60429-954-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	60429-954-10	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	60429-954-90	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	60429-954-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	60429-954-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	60429-954-90	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	60429-954-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	60429-954-10	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	60429-954-90	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	60429-954-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	60429-954-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	60429-954-90	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	60429-954-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	60429-954-10	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	60429-954-90	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	60429-954-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	60429-954-10	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	60429-954-90	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	60429-954-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A076161-001	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10
A076161-002	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10
A076161-003	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10
A076161-004	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076161-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	2004-06-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076161-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	2004-06-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076161-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	2004-06-10	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076161-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	2004-06-10	`d06236e962d9…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A076161-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076161-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076161-003	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076161-004	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	A076161-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076161-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076161-003	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076161-004	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076161-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076161-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076161-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076161-004	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076161-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076161-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076161-003	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076161-004	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
07a517fc-5845-3816-0f81-0a121804ec9e	Product name	6	20250107
171dd63c-7eea-ede4-c010-4c25ba0a1087	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60429-954-01	EA - Each	60429-954	0784ce0f-5809-4f24-8a2e-e0520dc2f6b6	1	2012-07-24
60429-954-10	EA - Each	60429-954	c0a83aab-d452-49ff-8ff6-f4113610371f	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOXAZOSIN MESYLATE	ACTIVE INGREDIENT	86P6PQK0MU	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
doxazosin mesylate	ACTIVE INGREDIENT	86P6PQK0MU	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
DOXAZOSIN	ACTIVE MOIETY	NW1291F1W8	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
doxazosin	ACTIVE MOIETY	NW1291F1W8	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
D&C yellow no. 10	INACTIVE INGREDIENT	35SW5USQ3G	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
FD&C yellow no. 6	INACTIVE INGREDIENT	H77VEI93A8	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
lactose	INACTIVE INGREDIENT	J2B2A4N98G	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
sodium lauryl sulfate	INACTIVE INGREDIENT	368GB5141J	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1
sodium starch glycolate type A potato	INACTIVE INGREDIENT	5856J3G2A2	DOXAZOSIN MESYLATE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	DOXAZOSIN MESYLATE TABLET [STATE OF FLORIDA DOH CENTRAL PHARMACY]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
86P6PQK0MU	DOXAZOSIN MESYLATE	77883-43-3	DOXAZOSIN MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197626	doxazosin mesylate 2 MG Oral Tablet	PSN	98a248f5-a79b-43ba-839f-014a77edf9c2	1
197626	doxazosin 2 MG Oral Tablet	SCD	98a248f5-a79b-43ba-839f-014a77edf9c2	1
197626	doxazosin (as doxazosin mesylate) 2 MG Oral Tablet	SY	98a248f5-a79b-43ba-839f-014a77edf9c2	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
60429-954-01	60429095401	100 TABLET in 1 BOTTLE (60429-954-01)	100 tablet	2011-07-20	0000-00-00	No	No	Current
60429-954-10	60429095410	1000 TABLET in 1 BOTTLE (60429-954-10)	1000 tablet	2011-07-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Doxazosin Mesylate	Golden State Medical Supply, Inc.	2021-04-22	HUMAN PRESCRIPTION DRUG LABEL	4
Doxazosin Mesylate	Aphena Pharma Solutions - Tennessee, LLC	2017-11-21	HUMAN PRESCRIPTION DRUG LABEL	2
DOXAZOSIN MESYLATE TABLETS, USP	State of Florida DOH Central Pharmacy	2015-01-03	HUMAN PRESCRIPTION DRUG LABEL	1